SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients

SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients

André J Scheen1,2 1Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Liège, Liège University, Liège, Belgium; 2Clinical Pharmacology Unit, CHU Liège, Center for Interdisciplinary Research on Medicines (CIRM), Li&egrave...

Full description

Bibliographic Details
Main Author: Scheen AJ
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
blood pressure
body weight
combined therapy
glucose control
hba1c
oral antidiabetic drug
Online Access:https://www.dovepress.com/sglt2-inhibitors-as-add-on-therapy-to-metformin-for-people-with-type-2-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/sglt2-inhibitors-as-add-on-therapy-to-metformin-for-people-with-type-2-peer-reviewed-article-DMSO

Similar Items